Anthropic Tops 2026 CNBC Disruptor 50 List Surpassing OpenAI as Enterprise AI Leader SeaStar ICUCW Stalls at 002 Consolidation Phase 20260514 KORU KRMD Stock Today Drops 179 Key Support at 364 20260518 BRC Group RILYP Earnings Outlook Key Metrics for Q1 2024 Jeff Bezos Discusses AI Tax Policy and Billionaire Criticism in CNBC Interview PSQ Holdings PSQH Q1 2026 Earnings Beat Revenue NA EPS 012 Jeff Bezos Defends Billionaires Hypes AI and Proposes Tax Overhaul in CNBC Interview Nvidia Earnings in Focus as Investors Await CEO Jensen Huangs Remarks on China Chip Policy and USChina Ties Gavin Newsoms Office Warns Against Branded Fuel as RipOffBut Studies Suggest Premium Gas May Offer Value Why US 10Year Bond Yields Serve as a Critical Market Barometer for Global Investors Jim Cramer Suggests VF Corporations PostEarnings Dip May Present a Buying Opportunity Standard Chartered CEO Apologizes for Controversial Lower Value Human Capital Remark Mixed Signals on Iran Nuclear Deal Keep Energy Markets on Edge Nvidia Stock Declines After Earnings Release Why Some Market Participants May Be Overlooking the LongTerm Picture Stepan Company SCL Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Biodesix Inc BDSX Q1 2026 Earnings Strong EPS Beat Overshadowed by Negative Stock Reaction JKS Q4 2025 Earnings Significant EPS Miss Despite Modest Share Gain GYRE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage CEVA Q1 2026 Earnings EPS Surprises by 122 Amid Strong Licensing Momentum SEB Q1 2026 Earnings Strong EPS Performance Amid Limited Visibility CHRW Q1 2026 Earnings EPS Beats Estimates Shares Rise 21 ICCM Q1 2026 Earnings WiderthanExpected Loss as IceCure Medical Advances Commercial Efforts MLYS Q1 2026 Earnings Narrowerthanexpected loss as clinicalstage company advances pipeline PG Q1 2026 Earnings EPS Slightly Misses Estimates Stock Gains 317 ADAMH Q1 2026 Earnings EPS Surges Past Estimates on Robust Interest Income AI FactChecking in Financial Analysis Experts Highlight Verification Techniques Arcturus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Pipeline Progress Continues